Archives: All Projects

Ceribell

Ceribell is a medical device and artificial intelligence data analytics platform that deploys a cloud-linked, portable electroencephalogram (“EEG”) headband to facilitate rapid point-of-care diagnosis and treatment of life threatening neurological…

Mission Bio

Mission Bio is a life science tools company focused on single cell genomics, proteomics and multi-omics solutions for oncology study and cell and gene therapy development.

Aerin Medical

Aerin Medical is medical technology company focused on the ear, nose and throat market providing non-invasive solutions for the treatment of chronic nasal conditions.

BenevolentAI

BenevolentAI is a clinical-stage drug discovery company seeking to combine artificial intelligence and machine learning with science to decipher complex disease biology, generate new insights and discover more effective medicines….

Goldfinch Bio

Goldfinch Bio is a precision medicine company focused on delivering disease-modifying medicines to people with kidney disease. The company’s lead program, GFB-887, is being studied in a variety of kidney…

Pulmonx

Pulmonx focuses on minimally invasive treatments for severe lung disease. The company’s platforms are designed to assess and treat patients with severe emphysema and chronic obstructive pulmonary disease who, despite…

Arbor Biotechnologies

Arbor Biotechnologies is a biotechnology company that aims to discover and develop the next generation of genetic medicines based on wholly owned genomic editors discovered from its machine learning/AI driven…

Endeavor BioMedicines

Endeavor BioMedicines is a clinical-stage precision medicine company that targets the core drivers of multiple terminal diseases, including oncology and fibrosis. The Company seeks to combine advancements in technology with…

Shoreline Biosciences

Shoreline Biosciences is a biotechnology company developing genetically engineered induced pluripotent stem cell (iPSC)-derived allogeneic natural killer and macrophage immunotherapies for the treatment of cancer.

Atea Pharmaceuticals

Atea Pharmaceuticals is a clinical-stage biopharmaceutical company developing direct anti-viral medicines to treat infectious diseases. Atea completed its IPO on the Nasdaq stock market in October 2020.